Use our pre-submission checklist
Avoid common mistakes on your manuscript.
1 Correction to: PharmacoEconomics (2018) 36(12):1463–1473 https://doi.org/10.1007/s40273-018-0709-3
Page 1467, Section 3 (Results), 1st paragraph, final sentence:
The sentence should read, “In addition, the patiromer-spironolactone-ACEI arm was associated with 0.19 greater total expected QALYs gained than the ACEI-only arm (2.79 versus 2.60 QALYs, respectively).”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bounthavong, M., Butler, J., Dolan, C.M. et al. Correction to: Cost-Effectiveness Analysis of Patiromer and Spironolactone Therapy in Heart Failure Patients with Hyperkalemia. PharmacoEconomics 37, 1071 (2019). https://doi.org/10.1007/s40273-019-00809-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40273-019-00809-1